XTXXFOTCPharmaceutical PreparationsFiscal year ends December 31

Adastra Holdings Ltd.

Financials through fiscal 2022, year ended Dec 31, 2022Last filing: 20-F on May 17, 2023

$0.01+0.00 (0.00%)

Close on Oct 19, 2026

Adastra Holdings Ltd. income statement

AnnualQuarterlyTTM

CAD USD

Millions of CAD, except per-share data. Shares in millions.

Line item	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Revenue	13	5.63	2.50
Cost of Revenue	7.18	3.68	1.71
Gross Profit	6.11	1.94	0.79
Research & Development	0	0.09	0.18
General & Administrative	0.69	0.32	0.23
Advertising Expenses	1.28	0.46	0.75
Operating Income	-0.80	-2.39	-7.17
Interest Expense	0.34	0.28	0.40
Pretax Income	-4.34	-2.76	-7.62
Income Tax Expense	-0.06	-0.02	0
Net Income incl. Noncontrolling Interests	-4.28	-2.75	-7.62
EPS (Basic)(per share)	-0.07	-0.05	-0.19
EPS (Diluted)(per share)	-0.07	-0.05	-0.19
Shares Outstanding (Basic, Weighted)(shares)	59	50	40
Shares Outstanding (Diluted, Weighted)(shares)	59	50	40
EBITDA	-0.30	-2.12	-7.07

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2022

Profitability, FY2022

Gross margin: 46.0%
Operating margin: -6.0%
Net margin: –
Return on equity, FY2022: –

Financial strength

Current ratio: 0.71
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.